1. Search Result
Search Result
Results for "

NSC 718781-d6

" in MedChemExpress (MCE) Product Catalog:

522

Inhibitors & Agonists

1

Screening Libraries

6

Fluorescent Dye

5

Biochemical Assay Reagents

22

Peptides

1

Inhibitory Antibodies

108

Natural
Products

113

Isotope-Labeled Compounds

8

Click Chemistry

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-101796

    Others Cancer
    NSC-70220 is a selective and allosteric SOS1 inhibitor. NSC-70220 inhibits allosteric site activation, and partially inhibited catalytic site activation. NSC-70220 has an anticancer effect .
    <em>NSC</em>-70220
  • HY-15827
    NSC 405020
    1 Publications Verification

    MMP Cardiovascular Disease Cancer
    NSC 405020 is a specific MMP14 inhibitor. NSC 405020 can directly interact with the hemopexin domain of MMP14. NSC 405020 reduces the expression of full length and active cleaved Notch3 (NICD3). NSC 405020 can be used to research vestibular schwannoma, hemostasis and thrombosis .
    <em>NSC</em> 405020
  • HY-141687

    CDK Apoptosis Cancer
    NSC 107512 is a potent inhibitor of cyclin-dependent kinase 9 (CDK9). NSC 107512 is a class of sangivamycin-like molecules (SLM). NSC 107512 inhibits growth and induces apoptosis of multiple myeloma tumors .
    <em>NSC</em> 107512
  • HY-134309

    Virus Protease Infection
    NSC 288387 is a pan-flavivirus MTase inhibitor. NSC 288387 binds to the SAM-binding pocket. NSC 288387 inhibits ZIKV with an IC50 of 0.2 μM. NSC 288387 also inhibits viral replication in cell culture .
    <em>NSC</em> 288387
  • HY-152168

    PERK Phosphatase Cancer
    NSC 295642 is a phosphatase inhibitor. NSC 295642 can significantly increase phospho-Erk cytonuclear differences in intact cells. NSC 295642 can be used for the research of cancer .
    <em>NSC</em> 295642
  • HY-N0837
    Veratramine
    1 Publications Verification

    NSC17821; NSC23880

    Others Cancer
    Veratramine(NSC17821; NSC23880) is useful as a signal transduction inhibitor for treating tumors.
    Veratramine
  • HY-19539

    Ras Cancer
    NSC-658497 is an effective inhibitor of Ras-GEF, SOS1. NSC-658497 binds to SOS1, competitively suppresses SOS1-Ras interaction, and dose-dependently inhibits SOS1 GEF activity. NSC-658497 showed dose-dependent efficacy in inhibiting Ras, downstream signaling activities, and associated cell proliferation .
    <em>NSC</em>-658497
  • HY-118365

    Others Infection Cancer
    NSC 140873 is an inhibitor of the RUNX1-CBFβ interaction. NSC 140873 can be used for research of viral infection and leukemia. NSC 140873 has an unstable structure and can be converted spontaneously in solution to a benzodiazepine (Ro5-3335) .
    <em>NSC</em> 140873
  • HY-B1714

    Others Cancer
    NSC 601980 analog is the analog of the NSC601980, NSC601980 shows antitumor activity in the yeast screening experiment, which can inhibit cell proliferation in the COLO 205 and HT29 with Log GI 50 of -6.6 and -6.9 respectively.
    <em>NSC</em> 601980 analog
  • HY-122258

    STAT TET Protein Cancer
    NSC-370284 is a selective inhibitor of ten-eleven translocation 1 (TET1) and 5-hydroxymethylcytosine (5hmC). NSC-370284 significantly inhibits the level of TET1 expression via targets STAT3/5 .
    <em>NSC</em>-370284
  • HY-110185

    DNA/RNA Synthesis Cancer
    NSC 617145 is a selective werner syndrome helicase (WRN) helicase inhibitor with an IC50 value of 230 nM. NSC 617145 inhibits WRN ATPase, and induces double-strand breaks (DSB) and chromosomal abnormalities. NSC 617145 shows selective for WRN over BLM, FANCJ, ChlR1, RecQ, and UvrD helicases .
    <em>NSC</em> 617145
  • HY-125169

    Autophagy Atg4 Cancer
    NSC 185058 is an inhibitor of ATG4B, a major cysteine protease. Inhibition of ATG4B using NSC 185058 markedly attenuates autophagic activity .
    <em>NSC</em> 185058
  • HY-B1476

    Endogenous Metabolite Metabolic Disease
    NSC 42196 is an endogenous metabolite.
    <em>NSC</em> 42196
  • HY-18594

    Others Others
    NSC-41589 is an N-[2-(methylsulfanyl) phenyl]acetamide.
    <em>NSC</em>-41589
  • HY-156780
    NSC 689534
    1 Publications Verification

    Cuproptosis Cancer
    NSC 689534 can form copper chelate with Cu 2+. NSC 689534/Cu 2+ complex is a potent oxidative stress inducer, and has antitumor activity .
    <em>NSC</em> 689534
  • HY-147290

    Histone Acetyltransferase Cancer
    NSC 694623 is a potent histone acetyltransferase (HAT) inhibitor with an IC50 value of 15.9 μM for recombinant HAT p300/CBP-associated factor (PCAF). NSC 694623 has antiproliferative activity against certain cancer cells. NSC 694623 can be used for researching anticancer .
    <em>NSC</em> 694623
  • HY-145330

    DNA/RNA Synthesis Cancer
    NSC639828 is a potent inhibitor of DNA polymerase α with an IC50 of 70 μM. NSC639828 has high antitumor activity. NSC639828 has the potential for researching cancer disease .
    <em>NSC</em>639828
  • HY-156328

    Apoptosis Cancer
    NSC 48160 inhibits the growth of the pancreatic cancer cells with IC50s of 84.3 μM for CPFAC-1 and 94.5 μM for BxPC-3. NSC 48160 also induces pancreatic cancer cell apoptosis. NSC 48160 can improve metabolic syndromes, such as NASH, obesity and lipid metabolism disorders .
    <em>NSC</em> 48160
  • HY-147288

    Histone Acetyltransferase Cancer
    NSC 694621 is a potent PCAF inhibitor, with an IC50 of 5.71 µM (PCAF/H31-21). NSC 694621 exhibits good activity of inhibiting the proliferation of cancer cells .
    <em>NSC</em> 694621
  • HY-147289

    Histone Acetyltransferase Cancer
    NSC 698600 is a potent PCAF inhibitor, with IC50 of 6.51 µM (PCAF/H31-21). NSC 698600 exhibits good activity of inhibiting the proliferation of cancer cells .
    <em>NSC</em> 698600
  • HY-144444

    EGFR Cancer
    NSC381467 is a potent and orally active inhibitor of EGFR tyrosine kinase (EGFR-TK). NSC381467 has strong antiproliferative activities. NSC381467 has the potential for the research of cancer diseases .
    <em>NSC</em>381467
  • HY-144445

    EGFR Cancer
    NSC114126 is a potent and orally active inhibitor of EGFR tyrosine kinase (EGFR-TK). NSC114126 has strong antiproliferative activities. NSC114126 has the potential for the research of cancer diseases .
    <em>NSC</em>114126
  • HY-19387
    Didox
    5+ Cited Publications

    NSC-324360

    DNA/RNA Synthesis Cancer
    Didox (NSC-324360) is a synthetic ribonucleotide reductase (RR) inhibitor.
    Didox
  • HY-15723A
    NSC 23766 trihydrochloride
    25+ Cited Publications

    Ras Apoptosis Cancer
    NSC 23766 trihydrochloride is an inhibitor of Rac1 activation.
    <em>NSC</em> 23766 trihydrochloride
  • HY-137843

    DNA/RNA Synthesis Cancer
    NSC 80467, a DNA damaging agent, selectively inhibits survivin. NSC 80467 preferentially inhibits DNA synthesis and results in induction of γH2AX and pKAP1, two markers of DNA damage .
    <em>NSC</em> 80467
  • HY-103366

    Checkpoint Kinase (Chk) Cancer
    NSC 109555 ditosylate is a potent, selective, ATP-competitive checkpoint kinase 2 (Chk2) inhibitor with an IC50 of 240 nM. NSC 109555 ditosylate can be used for the research of cancer .
    <em>NSC</em> 109555 ditosylate
  • HY-122066

    Others Infection
    NSC47924 is a laminin receptor (LR) inhibitor. NSC47924 affects 37/67 kDa LR cell surface localization and interaction with the cellular prion protein. NSC47924 can be used for testing prion diseases .
    <em>NSC</em>47924
  • HY-106423

    NSC 613862; (S)-(-)-NSC 613862

    Microtubule/Tubulin Cancer
    Mivobulin (NSC 613862) is a tubulin inhibitor, binds to tubulin in the region that overlaps the colchicine site, and inhibits tubulin polymerization. Mivobulin (NSC 613862) promotes the formation of abnormal polymers and a GTPase activity in the tubulin dimer. Anti-cancer activity .
    Mivobulin
  • HY-17393
    Carboplatin
    40+ Cited Publications

    NSC 241240

    DNA Alkylator/Crosslinker Autophagy DNA/RNA Synthesis Cancer
    Carboplatin (NSC 241240) is a DNA synthesis inhibitor which binds to DNA, inhibits replication and transcription and induces cell death. Carboplatin (NSC 241240) is a derivative of CDDP and a potent anti-cancer agent.
    Carboplatin
  • HY-123510

    Others Others
    NSC-670224 is toxic to Saccharomyces cerevisiae at low micromolar concentration (LC50: 3.2 μM) .
    <em>NSC</em>-670224
  • HY-118851

    Others Others
    NSC-77053 is a potent BoNT/E inhibitor with an IC50 and a Ki of 2.4 μM and 1.29 μM, respectively .
    <em>NSC</em>-77053
  • HY-144105

    MDM-2/p53 Cancer
    NSC405640 is a potent inhibitor of the MDM2-p53 interaction. NSC405640 rescues structural p53 mutations. NSC405640 selectively inhibits the growth of cell lines with wild-type p53 .
    <em>NSC</em>405640
  • HY-19820A

    Akt Ser/Thr Protease Neurological Disease Cancer
    NSC45586 sodium is an inhibitor of pleckstrin homology domain and leucine-rich repeat protein phosphatase (PHLPP). NSC45586 sodium targets the PP2C phosphatase domain in PHLPP1 and PHLPP2. NSC45586 sodium can activate AKT in neurons .
    <em>NSC</em>45586 sodium
  • HY-19820

    Akt Ser/Thr Protease Neurological Disease Cancer
    NSC45586 is an inhibitor of pleckstrin homology domain and leucine-rich repeat protein phosphatase (PHLPP). NSC45586 targets the PP2C phosphatase domain in PHLPP1 and PHLPP2. NSC45586 can activate AKT in neurons .
    <em>NSC</em>45586
  • HY-108937
    NSC 15364
    5+ Cited Publications

    VDAC Apoptosis Cardiovascular Disease Neurological Disease
    NSC 15364 is an inhibitor of VDAC1 oligomerization and apoptosis .
    <em>NSC</em> 15364
  • HY-18756

    SHP2 Phosphatase Apoptosis Others
    NSC-87877 is a potent inhibitor of Shp2 and Shp1 protein tyrosine phosphatases (SH-PTP2 and SH-PTP1), with IC50 values of 0.318 μM, 0.355 μM shp2 and shp1, respectively . NSC-87877 also inhibits dual-specificity phosphatase 26 (DUSP26) .
    <em>NSC</em>-87877
  • HY-114658

    NSC-109351

    Biochemical Assay Reagents Cancer
    Daunomycinone (NSC-109351) is a metabolite of daunomycin. Daunomycin is an antibiotic with antitumor activity .
    Daunomycinone
  • HY-144441

    EGFR Cancer
    NSC81111 is a potent and orally active EGFR-TK inhibitor with an IC50 of 0.15 nM. NSC81111 has anticaner effects .
    <em>NSC</em>81111
  • HY-15733
    Lucidin
    1 Publications Verification

    NSC 30546

    Others Cancer
    Lucidin (NSC 30546) is a natural component of Rubia cordifolia.
    Lucidin
  • HY-115492
    NSC668394
    1 Publications Verification

    PKC Cancer
    NSC668394 is a potent ezrin (Thr567) phosphorylation inhibitor, with a Kd of 12.59 μM. NSC668394 inhibit ezrin T567 phosphorylation caused by PKCΙ primarily via their binding to ezrin. NSC668394 can be used to prevent tumor metastasis .
    <em>NSC</em>668394
  • HY-103380
    NSC 625987
    1 Publications Verification

    CDK Cancer
    NSC 625987 is a specific and high-affinity CDK4 inhibitor with an IC50 of 0.2 μM for CDK4:cyclin D1. NSC 625987 shows >500-fold selectivity for CDK4 over CDK2 .
    <em>NSC</em> 625987
  • HY-119172

    Bacterial Infection Inflammation/Immunology Cancer
    NSC-60339, an efflux pump inhibitor and a substrate of AcrAB-TolC, is a polybasic terephthalic acid derivative studied as a potential cancer chemotherapeutic agent .
    <em>NSC</em>-60339
  • HY-117666
    NSC668036
    1 Publications Verification

    Wnt Inflammation/Immunology
    NSC668036 is a Dishevelled (Dvl) PDZ domain inhibitor with a Kd of 237 µM. NSC668036 blocks Wnt signaling by interrupting the Frizzled-Dvl interaction .
    <em>NSC</em>668036
  • HY-108638
    NSC 146109 hydrochloride
    1 Publications Verification

    MDM-2/p53 Apoptosis Cancer
    NSC 146109 hydrochloride is a small-molecule p53 activator that target MDMX and can be used for breast cancer research. NSC 146109 hydrochloride is a pseudourea derivative, promotes breast cancer cells to undergo apoptosis through activating p53 and inducing expression of proapoptotic genes .
    <em>NSC</em> 146109 hydrochloride
  • HY-123786

    Others Cancer
    NSC745887 (compound 25) is an anti-cancer agent. NSC745887 exhibits dose-dependent inhibition of proliferation in all 60 cancer cell lines .
    <em>NSC</em>745887
  • HY-111163

    Apoptosis Cancer
    NSC49652 is a reversible, orally active p75 neurotrophin receptor (p75 NTR, also known as NGFR, TNFRSF16, and CD271) agonist. NSC49652 targets the transmembrane domain of p75 NTR. NSC49652 induces apoptosis and affects the viability of melanoma cells .
    <em>NSC</em>49652
  • HY-130369

    Bacterial Necroptosis HSV Infection Cancer
    NSC10010 hydrochloride inhibits gammaherpesvirus associated B-lymphomas growth through activation of NF-kB and c-Myc-mediated signaling pathways. NSC10010 hydrochloride induces necrotic cell death in gammaherpesvirus infected B-cells. NSC10010 hydrochloride is also an inhibitor of Mtb ClpC1 ATPase .
    <em>NSC</em>10010 hydrochloride
  • HY-52155S

    Isotope-Labeled Compounds Others
    NSC 89275-d12 is the deuterium labeled NSC 89275[1].
    <em>NSC</em> 89275-d12
  • HY-Y0226S1

    Isotope-Labeled Compounds Others
    NSC 1940-d8 is the deuterium labeled NSC 1940[1].
    <em>NSC</em> 1940-d8
  • HY-Y0226S2

    Isotope-Labeled Compounds Others
    NSC 1940-d4 is the deuterium labeled NSC 1940[1].
    <em>NSC</em> 1940-d4

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: